Document ID: chunk:federal_register_of_legislation:F2021L00621:reg:9:p2
Version: federal_register_of_legislation:F2021L00621
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6326–7358

the 7 days before the clinical worsening of IgA nephropathy;
Note: biologic agent is defined in the Schedule 1 - Dictionary.
(12)      undergoing kidney transplantation before the clinical worsening of IgA nephropathy;
(13)      being overweight or obese for at least the 5 years before the clinical worsening of IgA nephropathy;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(14)      having smoked at least 5 pack-years of tobacco products in the 10 years before the clinical worsening of IgA nephropathy;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(15)      inhaling, ingesting or having cutaneous contact with an organic solvent in an unventilated and confined space:
(a)          for an average of at least 2 hours per week; and
(b)          for at least 1 year within the 5 years before the clinical worsening of IgA nephropathy;
Note: organic solvent is defined in the Schedule 1 - Dictionary.
(16)      inability to obtain appropriate clinical management for IgA nephropathy.